Structure Therapeutics Inc (GPCR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | GPCR | AMGN | VRTX | REGN | GSK |
| Company | Structure Therapeutics Inc | Amgen Inc | Vertex Pharmaceutic | Regeneron Pharmaceuticals | Gsk Plc ADR |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NYSE |
| Open | 55.66 | 306.72 | 484.45 | 999.00 | 41.11 |
| High | 55.66 | 307.96 | 486.42 | 1,007.43 | 41.46 |
| Low | 51.90 | 304.48 | 480.10 | 994.44 | 40.94 |
| Last | 53.07 | 305.02 | 483.04 | 1,002.95 | 41.21 |
| Change | -2.56 | -0.67 | -2.49 | +2.16 | -0.33 |
| % Change | -4.60% | -0.22% | -0.51% | +0.22% | -0.79% |
| Volume | 1,922,000 | 1,925,000 | 944,400 | 250,100 | 3,025,300 |
| 20-Day Average Volume | 1,612,970 | 2,316,610 | 1,215,520 | 388,660 | 4,324,595 |
| Previous Close | 55.63 | 305.69 | 485.53 | 1,000.79 | 41.54 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 40.61 | 308.18 | 451.55 | 983.83 | 44.04 |
| 20-Day Raw Stochastic | 66.86% | 36.72% | 95.09% | 79.51% | 12.93% |
| 20-Day Relative Strength | 67.99% | 55.48% | 73.98% | 62.19% | 41.38% |
| Weighted Alpha | +11.96 | +34.68 | +49.42 | +34.72 | +16.92 |
| Today's Opinion | 8% Buy | 72% Buy | 88% Buy | 88% Buy | 40% Buy |
| Previous Opinion | 8% Buy | 72% Buy | 88% Buy | 88% Buy | 40% Buy |
| Last Month's Opinion | 72% Sell | 56% Buy | 56% Buy | 72% Buy | 88% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +55.18% since 05/31/24 | -0.27% since 05/31/24 | +6.08% since 05/31/24 | +2.33% since 05/31/24 | -7.95% since 05/31/24 |
| Low | 33.56 on 06/03/24 | 303.85 on 06/03/24 | 453.73 on 06/03/24 | 979.26 on 06/03/24 | 40.51 on 06/03/24 |
| High | 62.74 on 06/03/24 | 311.48 on 06/03/24 | 486.42 on 06/07/24 | 1,016.00 on 06/06/24 | 42.44 on 06/05/24 |
| 1-Month | |||||
| %Chg | +34.94% since 05/07/24 | +1.57% since 05/07/24 | +17.75% since 05/07/24 | +3.40% since 05/07/24 | -6.66% since 05/07/24 |
| Low | 33.56 on 06/03/24 | 295.49 on 05/30/24 | 412.12 on 05/08/24 | 952.14 on 05/08/24 | 40.51 on 06/03/24 |
| High | 62.74 on 06/03/24 | 321.44 on 05/15/24 | 486.42 on 06/07/24 | 1,016.00 on 06/06/24 | 45.92 on 05/15/24 |
| 3-Month | |||||
| %Chg | +47.38% since 03/07/24 | +11.79% since 03/07/24 | +17.66% since 03/07/24 | +3.05% since 03/07/24 | -5.44% since 03/07/24 |
| Low | 33.56 on 06/03/24 | 260.68 on 04/19/24 | 391.01 on 04/18/24 | 875.22 on 04/26/24 | 39.15 on 04/18/24 |
| High | 62.74 on 06/03/24 | 322.60 on 05/03/24 | 486.42 on 06/07/24 | 1,016.00 on 06/06/24 | 45.92 on 05/15/24 |
| 6-Month | |||||
| %Chg | -11.34% since 12/07/23 | +12.42% since 12/07/23 | +36.47% since 12/07/23 | +18.11% since 12/07/23 | +14.47% since 12/07/23 |
| Low | 26.61 on 12/18/23 | 260.68 on 04/19/24 | 348.46 on 12/08/23 | 838.44 on 12/11/23 | 35.84 on 12/08/23 |
| High | 62.85 on 12/08/23 | 329.72 on 02/05/24 | 486.42 on 06/07/24 | 1,016.00 on 06/06/24 | 45.92 on 05/15/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 2,474,176 | 163,623,392 | 124,649,928 | 110,511,040 | 85,405,248 |
| Shares Outstanding, K | 46,621 | 536,435 | 258,053 | 110,186 | 2,072,440 |
| Annual Sales | 0 | 28,190,000,000 | 9,869,200,000 | 13,117,200,000 | 37,725,000,000 |
| Annual Net Income | -89,620,000 | 6,717,000,000 | 3,619,600,000 | 3,953,600,000 | 6,129,940,000 |
| Last Quarter Sales | 0 | 7,447,000,000 | 2,690,600,000 | 3,145,000,000 | 9,337,020,000 |
| Last Quarter Net Income | -26,040,000 | -113,000,000 | 1,099,600,000 | 722,000,000 | 1,326,430,000 |
| 60-Month Beta | N/A | 0.60 | 0.41 | 0.13 | 0.66 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.19 on 05/09/24 | 3.96 on 05/02/24 | 4.76 on 05/06/24 | 9.55 on 05/02/24 | 1.09 on 05/01/24 |
| Latest Earnings Date | 05/09/24 | 08/01/24 | 05/06/24 | 08/01/24 | 07/24/24 |
| Most Recent Dividend | N/A | 2.250 on 05/16/24 | N/A | N/A | 0.369 on 05/16/24 |
| Next Ex-Dividends Date | N/A | 05/16/24 | N/A | N/A | 05/16/24 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 16.41 | 32.24 | 26.97 | 10.28 |